Tag Archive for: CiteSpace

Original Article | Vol 5 | Issue 2 |  July-December 2025 | page: 20-27 | Na Chen

DOI: https://doi.org/10.13107/jrs.2025.v05.i02.175

Open Access License: CC BY-NC 4.0

Copyright Statement: Copyright © 2025; The Author(s).

Submitted Date: 25 Oct 2025, Review Date: 12 Nov 2025, Accepted Date: Nov 2025 & Published: 30 Dec 2025

Author: Na Chen [1]

[1] Department of Internal Medicine, Peking University Hospital, Beijing, China

Address of Correspondence
Na Chen,
Department of Internal Medicine, Peking University Hospital, Beijing, China. E-mail: 18901267905@163.com; CN09558@pku.edu.cn.

Abstract

Purpose: Extracorporeal shock wave therapy (ESWT) has emerged as a promising non-invasive intervention in cardiovascular disease (CVD) management, with increasing research interest over the past two decades. This study aimed to systematically analyze the research progress, hotspots, and development trends in ESWT for CVD using bibliometric methods, providing a comprehensive overview for subsequent research.
Methods: Literature related to ESWT and CVD was retrieved from the Web of Science Core Collection database, covering the period from 1999 to August 2025. The search strategy was defined as TS=([Shock wave OR Extracorporeal shock wave therapy OR ESWT] AND [Cardiovascular disease OR Coronary artery disease OR Myocardial ischemia OR Heart failure]). After excluding non-English studies, proceeding papers, retracted publications, and early access articles, 465 valid articles were included. Bibliometric analysis was performed using VOSviewer and CiteSpace software, focusing on publication trends, country/institution contributions, author collaborations, journal distributions, keyword co-occurrence, and cited references.
Results: A total of 465 publications involving 3019 authors from 1001 institutions across 55 countries were included, with 15,556 citations from 3104 sources. The annual number of publications has shown a steady growth trend since 2017. The United States (133 documents, 53.3 average citations) was the most influential country, followed by China (82 documents) and Germany (47 documents). Tohoku University (20 documents, 56.1 average citations) and Mayo Clinic (11 documents, 79.7 average citations) were leading institutions. Hiroaki Shimokawa and Hon-Kan Yip (18 documents each) were the most productive authors. Heart Rhythm (15 documents, 44.8 average citations) and Circulation (9 documents, 140.2 average citations) were core journals in this field. High-frequency keywords included “heart failure” (56 times), “coronary artery disease” (44 times), and “mortality” (41 times), with “outcome” being recent burst terms (2023–2025). The top-cited reference was a 2004 study on ESWT improving ischemia-induced myocardial dysfunction in pigs (87 citations).
Conclusion: ESWT for CVD is a rapidly developing research field, with the United States leading in academic influence. Current research focuses on myocardial ischemia, heart failure, and therapeutic efficacy/safety, while future trends may involve exploring mechanisms related to extracorporeal shock wave action and expanding clinical applications in comorbidities.
Keywords: Extracorporeal shock wave therapy, Cardiovascular disease, Bibliometrics, CiteSpace, VOSviewer

References:

1. GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392:1736-88.
2. Spadaccio C, Benedetto U. Coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in the treatment of multivessel coronary disease: Quo vadis? -A review of the evidences on coronary artery disease. Ann Cardiothorac Surg 2018;7:506-15.
3. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37:2129-200.
4. Chen N, Ji H. Cardiac shock wave therapy in cardiovascular diseases. J Regen Sci 2023;3:81-6.
5. Simplicio CL, Purita J, Murrell W, Santos GS, Dos Santos RG, Lana JF. Extracorporeal shock wave therapy mechanisms in musculoskeletal regenerative medicine. J Clin Orthop Trauma 2020;11:S309-18.
6. Kobayashi R, Camargo LS, Moya D. Latin American survey on shock wave therapy. J Regen Sci 2024;4:8-11.
7. Simplício CL, Rodrigues IJ, De Barros GA. Extracorporeal shock waves in metabolic inflammation. J Regen Sci 2024;4:18-25.
8. Kou D, Chen Q, Wang Y, Xu G, Lei M, Tang X, et al. The application of extracorporeal shock wave therapy on stem cells therapy to treat various diseases. Stem Cell Res Ther 2024;15:271.
9. Wang M, Yang D, Hu Z, Shi Y, Ma Y, Cao X, et al. Extracorporeal cardiac shock waves therapy improves the function of endothelial progenitor cells after hypoxia injury via activating PI3K/Akt/eNOS signal pathway. Front Cardiovasc Med 2021;8:747497.
10. Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, Abe K, et al. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation 2004;110:3055-61.
11. Fukumoto Y, Ito A, Uwatoku T, Matoba T, Kishi T, Tanaka H, et al. Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease. Coron Artery Dis 2006;17:63-70.
12. Jia N, Zhang R, Liu B, Liu B, Qi X, Lan M, et al. Efficacy and safety of cardiac shock wave therapy for patients with severe coronary artery disease: A randomized, double-blind control study. J Nucl Cardiol 2022;29:2404-19.
13. Li X, Zhang C, Liu C, Ma Y, Shi Y, Ye Y, et al. Principle and design of clinical efficacy observation of extracorporeal cardiac shock wave therapy for patients with myocardial ischemia-reperfusion injury: A prospective randomized controlled trial protocol. PLoS One 2023;18:e0294060.
14. Holfeld J, Nägele F, Pölzl L, Engler C, Graber M, Hirsch J, et al. Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: The CAST-HF trial. Eur Heart J 2024;45:2634-43.
15. van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics 2010;84:523-38.
16. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021;372:n71.
17. Zhang J, Zhang J, Jin J, Jiang X, Yang L, Fan S, et al. Artificial intelligence applied in cardiovascular disease: A bibliometric and visual analysis. Front Cardiovasc Med 2024;11:1323918.
18. Yeung AW. A revisit to the specification of sub-datasets and corresponding coverage timespans when using Web of Science Core Collection. Heliyon 2023;9:e21527.
19. Chen C. CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inform Sci Technol 2006;57:359-77.
20. Ito K, Fukumoto Y, Shimokawa H. Extracorporeal shock wave therapy for ischemic cardiovascular disorders. Am J Cardiovasc Drugs 2011;11:295-302.
21. Sung PH, Fu M, Chiang HJ, Huang CR, Chu CH, Lee MS, et al. Reduced effects of cardiac extracorporeal shock wave therapy on angiogenesis and myocardial function recovery in patients with end-stage coronary artery and renal diseases. Biomed J 2021;44:S201-9.
22. Uwatoku T, Ito K, Abe K, Oi K, Hizume T, Sunagawa K, et al. Extracorporeal cardiac shock wave therapy improves left ventricular remodeling after acute myocardial infarction in pigs. Coron Artery Dis 2007;18:397-404.
23. Kikuchi Y, Ito K, Ito Y, Shiroto T, Tsuburaya R, Aizawa K, et al. Double-blind and placebo-controlled study of the effectiveness and safety of extracorporeal cardiac shock wave therapy for severe angina pectoris. Circ J 2010;74:589-91.
24. Aicher A, Heeschen C, Sasaki K, Urbich C, Zeiher AM, Dimmeler S. Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: A new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation 2006;114:2823-30.

[Article Text HTML]       [Full Text PDF]